Effects of neurosteroids on kainate-induced seizures, neurotoxicity and lethality in mice

Polish Journal of Pharmacology

Volumn 49, Issue 6, 1997, Pages 411-417

  Leśkiewicz, Monika ^a   Budziszewska, Bogusława ^a   Jaworska Feil, Lucylla ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

3H kainate binding; Excitotoxicity; Hippocampus; Kainate; Lethality; Mice; Neurosteroids; Rat; Seizures

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA HYDROXY 5ALPHA PREGNAN 20 ONE; ALFAXALONE; ANDROSTERONE; EXCITOTOXIN; KAINIC ACID; NEUROSTEROID; PREGNENOLONE; PREGNENOLONE SULFATE; U 107; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; SEIZURE;

ANIMALS; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; LETHAL DOSE 50; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, KAINIC ACID; SEIZURES; STEROIDS;

EID: 0347672126     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Akhondzadeh S., Stone T. W.: Potentiation by neurosteroids of muscimol/adenosine interactions in rat hippocampus. Brain Res., 1995, 677, 311-318.
2. Belelli D., Lan N. C., Gee K. W.: Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci. Biobehav. Rev., 1990, 14, 315-322.
3. Bowlby M. R.: Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol. Pharmacol., 1993, 43, 813-819.
4. Budziszewska B., Siwanowicz J., Leśkiewicz M., Jaworska-Feil L., Lasoń W.: Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice. Eur. Neuropsychopharmacol., 1997, (in press).
5. A receptor J. Pharmacol. Exp. Ther., 1997, 280, 1284-1295.
6. Ferkany J. W., Borosky S. A., Clissold D. B., Pontecorvo M. J.: Dextromethorphan inhibits NMDA-induced convulsions. Eur. J. Pharmacol., 1988, 151, 151-154.
7. 2+ channel current in freshly isolated hippocampal CA1 neurons. Eur. J. Pharmacol., 1991, 202, 269-272.
8. Frye C. A.: The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in animal model of epilepsy. Brain Res., 1995, 696, 113-120.
9. Gasior M., Carter R. B., Goldberg S. R., Witkin J. M.: Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther., 1997, 282, 543-553.
10. Geddes J. W., Ulas J., Buzsaki G., Cotman C. W.: Excitatory amino acid receptors in human temporal lobe epilepsy and in animal models. In: Excitatory Amino Acids. Eds. Meldrum B. S., Moroni F., Simon R. P., Woods J. H., Fidia Research Foundation Symposium Series, Vol. 5, Raven Press, New York, 1991, 749-757.
11. Gee K. W., Bolger M. B., Brinton R. E., Coirini H., McEwen B. S.: Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther., 1988, 246, 803-812.
12. A receptor function. Mol. Pharmacol., 1994, 46, 977-985.
13. Holmes G. L., Weber D. A., Kloczko N., Zimmerman A. W.: Relationship of endocrine function to inhibition of kindling. Brain Res., 1984, 318, 55-59.
14. Honore T., Davies S. N., Drejer J., Fletcher E. J., Jacobsen P., Lodge D., Nielsen F. E.: Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science, 1988, 241, 701-703.
15. ++ response: structure-activity studies. J. Pharmacol. Exp. Ther., 1994, 271, 677-682.
16. Kleinrok Z., Czuczwar S. J., Turski L.: Prevention of kainic acid-induced seizure-like activity by antiepileptic drugs. Pol. J. Pharmacol. Pharm., 1980, 32, 261-264.
17. Kokate T. G., Svensson B. E., Rogawski M. A.: Anti-convulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther., 1994, 270, 1223-1229.
18. Landgren S., Aasly J., Backstrom T., Dubrovsky B., Danielsson E.: The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol. Scand., 1987, 131, 33-42.
19. Lasoń W., Simpson J. N., McGinty J. F.: The interaction between κ-opioid agonist, U-50,488H, and kainic acid: behavioral and histological assessments. Brain Res., 1989, 482, 333-339.
20. Litchfield J. T., Wilcoxon F.: A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 1949, 96, 99-103.
21. Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
22. Luntz-Leybman V., Freund R. K., Collins A. C.: 5α-Pregnan-3α-ol-20-one blocks nicotine-induced seizures and enhances paired-pulse inhibition. Eur. J. Pharmacol., 1990, 185, 239-242.
23. Maione S., Berrino L., Vitagliano S., Leyva J., Rossi F.: Pregnenolone sulfate increases the convulsant potency of N-methyl-D-aspartate in mice. Eur. J. Pharmacol., 1992, 219, 477-479.
24. A receptor. In: Neurosteroids and Brain Function. Eds. Costa E., Paul S. M., Fidia Research Foundation Symposium Series, Vol. 8, Thieme Medical Publishers, Inc., New York, 1991, 109-117.
25. McEwen B.: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci., 1991, 12, 141-146
26. Meldrum B. S.: Excitatory amino acid neurotransmission in epilepsy and anticonvulsant therapy. In: Excitatory Amino Acids. Eds. Meldrum B. S., Moroni F., Simon R. P., Woods J. W., Fidia Research Foundation Symposium Series, Vol. 5, Raven Press, New York, 1991, 655-670.
27. Paul S. M., Purdy R. H.: Neuroactive steroids. FASEB J., 1992, 6, 2311-2322.
28. 3 rat pituitary cells. Endocrinology, 1992, 131, 1883-1888.
29. Tamaru M., Yoneda Y., Ogita K., Shimizu J., Nagata Y.: Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus. Brain Res., 1991, 542, 83-90.
30. Wu F.-S., Gibbs T. T., Farb D. H.: Pregnenolone sulfate: a possible allosteric modulator at the N-methyl-D-aspartic receptor. Mol. Pharmacol., 1991, 401, 333-336.